StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

AXIM Biotechnologies's total debt was $186.49K at Jun 30, 2024. For fiscal 2023 it was $231.87K, up 1071.7% from the year before. The highest annual figure on record is $1.68M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$231.87K+1071.7%
FY2022Dec 31, 2022$19.79K+10893.9%
FY2021Dec 31, 2021$180-100.0%
FY2020Dec 31, 2020$1.68M+33439.4%
FY2019Dec 31, 2019$5.00K-98.8%
FY2018Dec 31, 2018$412.50K+8150.0%
FY2017Dec 31, 2017$5.00K0.0%
FY2016Dec 31, 2016$5.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024$186.49K+110.8%
Q1 FY2024Mar 31, 2024$209.34K+4100.2%
Q4 FY2023Dec 31, 2023$231.87K+1071.7%
Q3 FY2023Sep 30, 2023$91.67K+50828.9%
Q2 FY2023Jun 30, 2023$88.48K-93.5%
Q1 FY2023Mar 31, 2023$4.98K-99.6%
Q4 FY2022Dec 31, 2022$19.79K+10893.9%
Q4 FY2021Dec 31, 2021$180-100.0%
Q3 FY2021Sep 30, 2021$1.37M+140648.9%
Q2 FY2021Jun 30, 2021$1.34M+60925.7%
Q1 FY2021Mar 31, 2021$180-96.4%
Q4 FY2020Dec 31, 2020$1.68M+33439.4%
Q3 FY2020Sep 30, 2020$973-80.5%
Q2 FY2020Jun 30, 2020$2.19K-56.2%
Q1 FY2020Mar 31, 2020$5.00K0.0%
Q4 FY2019Dec 31, 2019$5.00K-98.8%
Q3 FY2019Sep 30, 2019$5.00K-98.8%
Q2 FY2019Jun 30, 2019$5.00K-60.0%
Q1 FY2019Mar 31, 2019$5.00K0.0%
Q4 FY2018Dec 31, 2018$412.50K+8150.0%
Q3 FY2018Sep 30, 2018$412.50K+8150.0%
Q2 FY2018Jun 30, 2018$12.50K+150.0%
Q1 FY2018Mar 31, 2018$5.00K0.0%
Q4 FY2017Dec 31, 2017$5.00K–
Q3 FY2017Sep 30, 2017$5.00K–
Q2 FY2017Jun 30, 2017$5.00K–
Q4 FY2016Dec 31, 2016$5.00K–

More AXIM Biotechnologies figures

See a number that looks wrong?